Eledon Pharmaceuticals (ELDN) Profit After Tax Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.64% |
| Dec 31, 2025 | -12.03% |
| Sep 30, 2025 | -23.23% |
| Jun 30, 2025 | -34.10% |
| Mar 31, 2025 | 4.50% |
| Dec 31, 2024 | -60.85% |
| Sep 30, 2024 | 95.57% |
| Jun 30, 2024 | -61.46% |
| Mar 31, 2024 | -37.09% |
| Dec 31, 2023 | -45.76% |
| Sep 30, 2023 | -23.16% |
| Jun 30, 2023 | -83.17% |
| Mar 31, 2023 | -30.87% |
| Dec 31, 2022 | -94.27% |
| Sep 30, 2022 | -28.66% |
| Jun 30, 2022 | -6.78% |
| Mar 31, 2022 | -48.32% |
| Dec 31, 2021 | -18.70% |
| Sep 30, 2021 | -36.99% |
| Jun 30, 2021 | -49.10% |
| Mar 31, 2021 | 5.75% |
| Dec 31, 2020 | 11.73% |
| Sep 30, 2020 | 12.32% |
| Jun 30, 2020 | 22.00% |
| Mar 31, 2020 | 9.22% |
| Dec 31, 2019 | 7.77% |
| Sep 30, 2019 | 14.66% |
| Jun 30, 2019 | 6.90% |
| Mar 31, 2019 | -0.14% |
| Dec 31, 2018 | 3.71% |
| Sep 30, 2018 | -0.77% |